TCR2 Therapeutics (TCRR) Net Income

Price: $1.48
Market Cap: $58.11M
Avg Volume: 325.04K
Country: US
Industry: Biotechnology
Sector: Healthcare
Beta: 1.93322
52W Range: $0.821-3.88
Website: TCR2 Therapeutics

What is TCR2 Therapeutics's Net Income?

  • TCR2 Therapeutics's annual net income as of FY 2022 is $-151.82M.
  • TCR2 Therapeutics's quarterly net income as of Q1 2023 is $-40.40M.

What is Net Income?

Net income is the total profit of a company after all expenses and taxes have been deducted from revenue. It is also known as net profit or net earnings and is a key indicator of a company's financial performance and profitability.

Related Metrics

Other important metrics to assess TCR2 Therapeutics's financial health include:

  • Net Income Growth - the rate at which a company's net income is growing:
    • Annual Growth: -52.12%
  • Net Income Ratio - net income divided by revenue:
    • Annual: 0.00%
    • Quarterly: 0.00%
  • Net Income Per Share - net income divided by the number of shares outstanding:
    • Annual: $-3.93

These metrics provide insights into TCR2 Therapeutics's financial health and its profitability. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.

Annual Net Income

$-151.82M

Quarterly Net Income

$-40.40M

Historical Annual Net Income
$0.00$0.00-$40.00M-$40.00M-$80.00M-$80.00M-$120.00M-$120.00M-$160.00M-$160.00MNet Income (Annual)20172017201820182019201920202020202120212022202220232023
Historical Quarterly Net Income
$0.00$0.00-$20.00M-$20.00M-$40.00M-$40.00M-$60.00M-$60.00M-$80.00M-$80.00MNet Income (Quarterly)201820182019201920202020202120212022202220232023
Annual Net Income Growth
19.26%19.26%-0.00%-0.00%-19.26%-19.26%-38.51%-38.51%-57.77%-57.77%-77.02%-77.02%-96.28%-96.28%Net Income Growth (%)20172017201820182019201920202020202120212022202220232023
Annual Net Income Per Share
$0.00$0.00$-1.00$-1.00$-2.00$-2.00$-3.00$-3.00$-4.00$-4.00Net Income Per Share20172017201820182019201920202020202120212022202220232023

TCR2 Therapeutics Historical Net Income Metrics

The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2022.

Year Net Income Net Income Growth Net Income Ratio Net Income Per Share
2022 $-151.82M -52.12% 0.00% $-3.93
2021 $-99.81M -48.69% 0.00% $-2.63
2020 $-67.12M -41.02% 0.00% $-2.40
2019 $-47.60M -96.28% 0.00% $-2.26
2018 $-24.25M -85.55% 0.00% $-1.05
2017 $-13.07M -31.82% 0.00% $-2.55
2016 $-9.91M 0.00% 0.00% $-1.93